Keith Roper

Title: The Innovations of Keith Roper

Introduction

Keith Roper is an accomplished inventor based in Salt Lake City, UT. He has made significant contributions to the field of biotechnology, particularly in the development of polysaccharide antigens. His work has implications for vaccine development, showcasing his innovative approach to addressing health challenges.

Latest Patents

Keith Roper holds a patent for a high molecular weight polysaccharide intracellular adhesin (SAE) antigen. This antigen has the general structure of poly-1,6,β-2-amidoglucopyranoside, which is variably substituted with N-acetyl and O-succinyl substituents. The patent describes a method for isolating this antigen, which can be utilized in vaccines, either alone, conjugated to an immunogenic protein, or with an immunogenic adjuvant. He has 1 patent to his name.

Career Highlights

Keith Roper is currently employed at Merck & Company, Inc., a leading global healthcare company. His role at Merck allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Keith has worked alongside notable colleagues such as Joseph G. Joyce and James C. Cook, III. These collaborations have further enhanced his research and innovation capabilities.

Conclusion

Keith Roper's contributions to the field of biotechnology, particularly through his patent on polysaccharide antigens, highlight his role as an innovative inventor. His work at Merck & Company, Inc. continues to influence vaccine development and public health.